| 000 | 01457 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250517095732.0 | ||
| 264 | 0 | _c20171204 | |
| 008 | 201712s 0 0 eng d | ||
| 022 | _a1573-904X | ||
| 024 | 7 |
_a10.1007/s11095-016-1940-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHirvonen, Liisa M | |
| 245 | 0 | 0 |
_aHydrodynamic Radii of Ranibizumab, Aflibercept and Bevacizumab Measured by Time-Resolved Phosphorescence Anisotropy. _h[electronic resource] |
| 260 |
_bPharmaceutical research _c08 2016 |
||
| 300 |
_a2025-32 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAngiogenesis Inhibitors _xanalysis |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aAnisotropy |
| 650 | 0 | 4 |
_aBevacizumab _xanalysis |
| 650 | 0 | 4 | _aCattle |
| 650 | 0 | 4 | _aHydrodynamics |
| 650 | 0 | 4 |
_aLuminescent Measurements _xmethods |
| 650 | 0 | 4 |
_aRanibizumab _xanalysis |
| 650 | 0 | 4 |
_aReceptors, Vascular Endothelial Growth Factor _xanalysis |
| 650 | 0 | 4 |
_aRecombinant Fusion Proteins _xanalysis |
| 650 | 0 | 4 |
_aSerum Albumin, Bovine _xanalysis |
| 700 | 1 | _aFruhwirth, Gilbert O | |
| 700 | 1 | _aSrikantha, Nishanthan | |
| 700 | 1 | _aBarber, Matthew J | |
| 700 | 1 | _aNeffendorf, James E | |
| 700 | 1 | _aSuhling, Klaus | |
| 700 | 1 | _aJackson, Timothy L | |
| 773 | 0 |
_tPharmaceutical research _gvol. 33 _gno. 8 _gp. 2025-32 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s11095-016-1940-2 _zAvailable from publisher's website |
| 999 |
_c26059679 _d26059679 |
||